Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR8 | P51685 | 9/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 9/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 10/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.58 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5396159 | 0.87 | CCR8 (1.00) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| SCHEMBL5402076 | 0.86 | CCR8 (0.78) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| Hydrochloric Acid SCHEMBL5444699 | 0.86 | CCR8 (0.98) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| SCHEMBL5193996 | 0.85 | CCR8 (0.73) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| SCHEMBL5434876 | 0.85 | CCR8 (0.82) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| SCHEMBL5197706 | 0.85 | CCR8 (0.76) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| SCHEMBL5390492 | 0.84 | CCR8 (0.84) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| SCHEMBL5395594 | 0.84 | CCR8 (0.80) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| SCHEMBL5401997 | 0.84 | CCR8 (1.00) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| SCHEMBL4234682 | 0.83 | CCR8 (0.72) | CCR8KCNH2CYP2D6CYP3A4USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2007509141-A | — | — | 2007-04-12 | — | — | JP | claimed |
| EP-1678178-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | AstraZeneca AB (SE) | 2006-07-12 | — | — | EP | claimed |
| WO-2005040167-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2005-05-06 | — | — | WO | claimed |
| EP-1869046-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | AstraZeneca AB (SE) | 2007-12-26 | — | — | EP | disclosed |
| WO-2006107252-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2006-10-12 | — | — | WO | disclosed |